Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Matthew Sussman, Manuela Di Fusco, Charles Y. Tao, Jennifer D. Guo, John A. Gillespie, Mauricio Ferri, Nicholas Adair, Matthew S. Cato, Ilnaz Shirkhorshidian & Geoffrey D. Barnes. (2021) The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model. Journal of Medical Economics 24:1, pages 1070-1082.
Read now
Read now
Michala Herskind Sejr, Sam Riahi, Torben Bjerregaard Larsen, Jens Cosedis Nielsen & Peter Brønnum Nielsen. (2017) Premature atrial complexes in an ischemic stroke population and risk of recurrent stroke: a systematic review. Expert Review of Cardiovascular Therapy 15:6, pages 447-455.
Read now
Read now
Articles from other publishers (28)
Mohammed Obeidat, Malcolm Burgess & Gregory Y.H. Lip. (2022) Atrial Fibrillation in Heart Failure. Cardiology Clinics 40:2, pages 245-258.
Crossref
Crossref
Anna Artmann, Anne Christin Rahn, Sascha Köpke, Götz Thomalla, Christoph Heesen & Anna Christina Alegiani. (2022) Risk communication in acute stroke patients – from qualitative data to a pilot randomised controlled trial. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 169, pages 19-27.
Crossref
Crossref
Naja E. Vinding, Søren L. Kristensen, Rasmus Rørth, Jawad H. Butt, Lauge Østergaard, Jonas B. Olesen, Christian Torp‐Pedersen, Gunnar H. Gislason, Lars Køber, Christina Kruuse, Søren P. Johnsen & Emil L. Fosbøl. (2022) Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation. Journal of the American Heart Association 11:4.
Crossref
Crossref
Vincent Thijs, Klaus K. Witte, Carmel Guarnieri, Koji Makino, Dominic Tilden, John Gillespie & Marianne Huynh. (2021) Cost‐effectiveness of insertable cardiac monitors for diagnosis of atrial fibrillation in cryptogenic stroke in Australia. Journal of Arrhythmia 37:4, pages 1077-1085.
Crossref
Crossref
Amélie Gabet, Charles Guenancia, Gauthier DuloquinValérie Olié & Yannick Béjot. (2021) Ischemic Stroke With Atrial Fibrillation: Characteristics and Time Trends 2006 to 2017 in the Dijon Stroke Registry. Stroke 52:6, pages 2077-2085.
Crossref
Crossref
Irene Escudero-Martínez, Rafael F. Ocete, Fernando Mancha, Ángela Vega, Pilar Piñero, Antonio López-Rueda, Elena Fajardo, Pilar Algaba, José Román Fernández-Engo, Eva M. Martín-Sánchez, Alejandro Galvao-Carmona, Elena Zapata-Arriaza, Lucía Lebrato, Blanca Pardo-Galiana, Juan Antonio Cabezas, María Irene Ayuso, Alejandro González, Francisco Moniche & Joan Montaner. (2020) Prevalence and risk factors of silent brain infarcts in patients with AF detected by 3T-MRI. Journal of Neurology 267:9, pages 2675-2682.
Crossref
Crossref
Erin Mathiesen Hald, Maja‐Lisa Løchen, Ellisiv B. Mathiesen, Tom Wilsgaard, Inger Njølstad, Sigrid K. Brækkan & John‐Bjarne Hansen. (2020) Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study. Research and Practice in Thrombosis and Haemostasis 4:6, pages 1004-1012.
Crossref
Crossref
José Tarcísio Medeiros Vasconcelos, Carlos Eduardo Duarte & Silas dos Santos Galvão Filho. (2020) Fibrilação Atrial e Tromboembolismo Sistêmico – Relação Causal ou uma Mensagem de Doença Atrial?. Journal of Cardiac Arrhythmias 32:3, pages 200-208.
Crossref
Crossref
José Tarcísio Medeiros Vasconcelos, Carlos Eduardo Duarte & Silas dos Santos Galvão Filho. (2020) Atrial Fibrillation and Systemic Thromboembolism – Causal Correlation or a Message of Atrial Disease?. Journal of Cardiac Arrhythmias 32:3, pages 200-208.
Crossref
Crossref
Mohammed Obeidat, Malcolm Burgess & Gregory Y.H. Lip. (2020) Atrial Fibrillation in Heart Failure. Heart Failure Clinics 16:1, pages 107-120.
Crossref
Crossref
Michala Herskind Sejr, Ole May, Dorte Damgaard, Birgitte Forsom Sandal & Jens Cosedis Nielsen. (2019) External continuous ECG versus loop recording for atrial fibrillation detection in patients who had a stroke. Heart 105:11, pages 848-854.
Crossref
Crossref
Arnold J. Greenspon. 2019. Stroke Prevention in Atrial Fibrillation. Stroke Prevention in Atrial Fibrillation
1
10
.
Oto Petrík, Iuliia Travkina, Rastislav Bažík, Ivan Vulev & Eva Unčovská. (2018) The first administration of idarucizumab with subsequent intravenous thrombolysis and mechanical thrombectomy in Slovakia (a case report). Neurologie pro praxi 19:5, pages 376-379.
Crossref
Crossref
Jessica Orchard, Nicole Lowres, Lis Neubeck & Ben Freedman. (2018) Atrial fibrillation: is there enough evidence to recommend opportunistic or systematic screening?. International Journal of Epidemiology 47:5, pages 1372-1378.
Crossref
Crossref
Norio Tanahashi, Takenori Yamaguchi, Hideto Awano & Hiroaki Matsuda. (2018) Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes. Journal of Stroke and Cerebrovascular Diseases 27:5, pages 1302-1310.
Crossref
Crossref
Søren Paaske Johnsen, Lene Worsaae Dalby, Tomas Täckström, Jens Olsen & Anina Fraschke. (2017) Cost of illness of atrial fibrillation: a nationwide study of societal impact. BMC Health Services Research 17:1.
Crossref
Crossref
Michala Herskind Sejr, Jens Cosedis Nielsen, Dorte Damgaard, Birgitte Forsom Sandal & Ole May. (2017) Atrial fibrillation detected by external loop recording for seven days or two-day simultaneous Holter recording: A comparison in patients with ischemic stroke or transient ischemic attack. Journal of Electrocardiology 50:3, pages 287-293.
Crossref
Crossref
Fredrik BuchwaldBo NorrvingJesper Petersson. (2016) Atrial Fibrillation in Transient Ischemic Attack Versus Ischemic Stroke. Stroke 47:10, pages 2456-2461.
Crossref
Crossref
Kristina H. Vinther, Claus Tveskov, Sören Möller, Thomas Rosen, Soren Auscher, Armin Osmanagic & Kenneth Egstrup. (2016) Prevalence and Prognostic Significance of Runs of Premature Atrial Complexes in Ischemic Stroke Patients. Journal of Stroke and Cerebrovascular Diseases 25:10, pages 2338-2343.
Crossref
Crossref
Jean-Benoît Thambo & Pauline Renou. (2015) The future of left atrial appendage occlusions: When extraordinary claims require evidence…. Archives of Cardiovascular Diseases 108:12, pages 613-616.
Crossref
Crossref
Sudarone Thihalolipavan & Daniel P. Morin. (2015) Atrial Fibrillation and Heart Failure: Update 2015. Progress in Cardiovascular Diseases 58:2, pages 126-135.
Crossref
Crossref
Leif FribergMårten RosenqvistArne LindgrenAndreas TeréntBo NorrvingKjell Asplund. (2014) High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke. Stroke 45:9, pages 2599-2605.
Crossref
Crossref
Tereza Lanitis, Thitima Kongnakorn, Lena Jacobson & Anna De Geer. (2014) Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation. Thrombosis Research 134:2, pages 278-287.
Crossref
Crossref
Christopher J. Boos, Michael Nam & A. J. Camm. (2013) Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure. Heart Failure Reviews 19:3, pages 391-401.
Crossref
Crossref
Søren Paaske JohnsenMarie Louise SvendsenMorten Lock HansenAxel BrandesFrank MehnertSteen Elkjær Husted. (2014) Preadmission Oral Anticoagulant Treatment and Clinical Outcome Among Patients Hospitalized With Acute Stroke and Atrial Fibrillation. Stroke 45:1, pages 168-175.
Crossref
Crossref
P. Kamtchueng & E. Teiger. (2013) Traitement préventif non médicamenteux des accidents thromboemboliques (AVC ischémiques). Annales de Cardiologie et d'Angéiologie 62:6, pages 411-418.
Crossref
Crossref
Deena M. Nasr, Waleed Brinjikji, Harry J. Cloft & Alejandro A. Rabinstein. (2013) Racial and Ethnic Disparities in the Use of Intravenous Recombinant Tissue Plasminogen Activator and Outcomes for Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases 22:2, pages 154-160.
Crossref
Crossref
Kwangsoo Kim. (2012) Relation of Stroke Risk Factors to Severity and Disability after Ischemic Stroke. Korean Journal of Stroke 14:3, pages 136.
Crossref
Crossref